Topline data from Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025. Fourth positive DSMB review for efzofitimod in Phase 3 EFZO-FIT study reinforces ...
Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025. Fourth positive DSMB review for efzofitimod in Phase 3 EFZO-FIT™ study ...
Two posters presented at the 2025 American Academy of Dermatology Annual Meeting highlighted the importance of improving ...
Co., Ltd. (referred to as "Longbio"), a leading biotech company dedicated to developing innovative biologic treatments for allergy, respiratory, dermatology, hematology, ophthalmology, and other ...
UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare ...
NCX 470 0.1% achieved an intraocular pressure of less than or equal to 18 mmHg compared to latanoprost 0.005% in the trial.
The Sixers have fielded plenty of horrid teams in the last decade, but one group from December 2015 takes the cake.
N.V. announced the presentation of multiple posters describing the utility of vilobelimab in pyoderma gangrenosum and ...
HAE attack rate maintained for at least 1.5 years in CHAPTER-1 OLE study; median proportion of days with symptoms in OLE was further reduced to zero days; All part ...
Much of cell behavior is governed by the actions of biomolecular condensates: building block molecules that glom together and scatter apart as needed. Biomolecular condensates constantly shift their ...
People on MSN12d
Bride-to-Be Is ‘Livid’ That Her Fiancé’s Parents Plan to Vacation at the Same Resort as Them During Their HoneymoonA bride-to-be documented on Reddit’s “Am I the A------” forum why she is “so angry” after her fiancé’s parents decided to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback